Education
About Us
Working with TipRanks
Follow Us
Icon plc (ICLR)
NASDAQ:ICLR
ICLR Stock Chart & Stats
$99.70
-$3.85(-1.73%)
At close: 4:00 PM EST
$99.70
-$3.85(-1.73%)
Day’s Range― - ―
52-Week Range$66.57 - $211.00
Previous CloseN/A
Volume330.38K
Average Volume (3M)2.70M
Market Cap
$7.61B
Enterprise Value$10.72B
Total Cash (Recent Filing)$468.89M
Total Debt (Recent Filing)$3.57B
Price to Earnings (P/E)1437.4
Beta1.10
Next Earnings
Apr 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding76,359,930
10 Day Avg. Volume1,036,228
30 Day Avg. Volume2,703,713
Financial Highlights & Ratios
PEG Ratio0.76
Price to Book (P/B)1.82
Price to Sales (P/S)2.09
P/FCF Ratio15.46
Enterprise Value/Market Cap1.41
Enterprise Value/Revenue1.32
Enterprise Value/Gross Profit4.93
Enterprise Value/Ebitda9.09
Forecast
1Y Price Target
$121.00Price Target Upside21.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)12.63
Revenue Forecast (FY)$7.98B
Bulls Say, Bears Say
Bulls Say
Cash Flow ResilienceManagement states cash balances are unaffected and the company generates meaningful free cash flow, supporting financial stability while a comprehensive audit review proceeds.
Strategic Partnerships And TechnologyThe company maintains strategic partnerships with large pharmaceutical firms and ongoing investments in clinical trial technology, which could support upside if operational credibility is clarified.
ValuationAnalyst notes ICLR's valuation is attractively low relative to peers and the market, creating a compelling risk/reward opportunity for prospective investors.
Bears Say
Accounting InvestigationAn ongoing internal investigation into revenue recognition remains a material risk and could uncover additional financial control weaknesses that would undermine confidence in reported results.
AI Disruption RiskPersistent market fears that artificial intelligence could disintermediate contract research organizations add an overhang that depresses investor sentiment and valuation.
Client Cancellations And Margin PressureHigh client cancellations combined with widespread margin pressures are reducing profitability and putting additional strain on the company's growth outlook.
Icon News
ICLR FAQ
What was Icon plc’s price range in the past 12 months?
Icon plc lowest stock price was $66.57 and its highest was $211.00 in the past 12 months.
What is Icon plc’s market cap?
Icon plc’s market cap is $7.61B.
When is Icon plc’s upcoming earnings report date?
Icon plc’s upcoming earnings report date is Apr 29, 2026 which is in 36 days.
How were Icon plc’s earnings last quarter?
Currently, no data Available
Is Icon plc overvalued?
According to Wall Street analysts Icon plc’s price is currently Undervalued.
Does Icon plc pay dividends?
Icon plc does not currently pay dividends.
What is Icon plc’s EPS estimate?
Icon plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Icon plc have?
Icon plc has 76,359,930 shares outstanding.
What happened to Icon plc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Icon plc?
Currently, no hedge funds are holding shares in ICLR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Icon Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$121.00 (21.36% Upside)
$121.00 (21.36% Upside)
Blogger Sentiment
Bullish
ICLR Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 308.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $61.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.80%
12-Months-Change
Fundamentals
Return on Equity
6.32%
Trailing 12-Months
Asset Growth
-4.09%
Trailing 12-Months
Company Description
Icon plc
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
ICLR Stock 12 Month Forecast
Average Price Target
$121.00
▲(21.36% Upside)
Technical Analysis
Ownership Overview
0.40% Insiders
36.10% Mutual Funds
53.08% Other Institutional Investors
8.30% Public Companies and
Individual Investors